hormone. Incretin mimetics are substances that mimic the actions of incretin hormones such as GLP-1 and GIP.

Originally developed to treat type 2 diabetes, some GLP-1 agonists have been approved to treat obesity. They mimic the actions of the endogenous incretin hormone GLP-1, which is released in the small intestine